Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

804
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
804
Psychoneuroimmunology: Diabetes and Cancer01:19

Psychoneuroimmunology: Diabetes and Cancer

108
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
108
Autoimmune Disorders01:29

Autoimmune Disorders

1.0K
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
1.0K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.5K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.5K
Cancer Vaccines01:30

Cancer Vaccines

602
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
602
Cancer Therapies02:49

Cancer Therapies

8.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cross-disorder comparison of brain structures among 4836 individuals with mental disorders and controls utilizing danish population-based clinical MRI scans.

Molecular psychiatry·2026
Same author

Post-infection sequelae of COVID-19 and other infectious diseases-a nationwide Danish study with 40-month follow-up.

Nature communications·2026
Same author

Covert consciousness: what's in a name?

Brain : a journal of neurology·2025
Same author

Spontaneous Eye Blinking as a Potential Clinical Marker for Arousal in the Intensive Care Unit.

Neurocritical care·2025
Same author

Response to Letter to the Editor for: "The Pupillary Light-Off Reflex in Acute Disorders of Consciousness".

Neurocritical care·2025
Same author

Near-Infrared Spectroscopy to Assess Covert Volitional Brain Activity in Intensive Care.

Neurocritical care·2025

Related Experiment Video

Updated: Nov 6, 2025

Induction and Clinical Scoring of Chronic-Relapsing Experimental Autoimmune Encephalomyelitis
26:48

Induction and Clinical Scoring of Chronic-Relapsing Experimental Autoimmune Encephalomyelitis

Published on: July 4, 2007

18.4K

Autoimmune Encephalitis Related to Cancer Treatment With Immune Checkpoint Inhibitors: A Systematic Review.

Vardan Nersesjan1, Oskar McWilliam1, Lars-Henrik Krarup1

  • 1From the Department of Neurology (V.N., O.M., L.-H.K., D.K.), Rigshospitalet, Copenhagen University Hospital; and Department of Clinical Medicine (D.K.), Faculty of Health and Medical Sciences, University of Copenhagen, Denmark.

Neurology
|May 6, 2021
PubMed
Summary

Immune checkpoint inhibitor-associated autoimmune encephalitis (ICPI-AIE) presents heterogeneously, often with nonlimbic involvement and specific MRI/EEG findings. Intraneuronal antibodies predict poorer outcomes in patients receiving ICPI therapy.

More Related Videos

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

852
Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
06:19

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Published on: September 9, 2022

4.0K

Related Experiment Videos

Last Updated: Nov 6, 2025

Induction and Clinical Scoring of Chronic-Relapsing Experimental Autoimmune Encephalomyelitis
26:48

Induction and Clinical Scoring of Chronic-Relapsing Experimental Autoimmune Encephalomyelitis

Published on: July 4, 2007

18.4K
Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

852
Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
06:19

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Published on: September 9, 2022

4.0K

Area of Science:

  • Neuroimmunology
  • Oncology
  • Clinical Neurology

Background:

  • Immune checkpoint inhibitors (ICPIs) are revolutionizing cancer treatment.
  • Adverse events, including autoimmune encephalitis (ICPI-AIE), are an emerging concern.
  • Understanding ICPI-AIE is crucial for managing patients undergoing ICPI therapy.

Purpose of the Study:

  • To define the clinical and laboratory characteristics of ICPI-associated autoimmune encephalitis.
  • To identify patterns and predictors of ICPI-AIE.
  • To inform future research and clinical management.

Main Methods:

  • Systematic literature search of PubMed, Cochrane Library, and Embase (2015-2020).
  • Inclusion of studies reporting cases of ICPI-AIE.
  • Analysis of patient demographics, cancer types, ICPI used, clinical presentation, and laboratory findings.

Main Results:

  • 54 patients with ICPI-AIE identified across 39 studies.
  • Melanoma and non-small cell lung cancer were common; nivolumab was the most frequent ICPI.
  • Nonlimbic AIE was more common than limbic AIE; specific MRI, EEG, and CSF findings were noted.
  • Intraneuronal antibodies predicted a lack of improvement with first-line immunotherapy.

Conclusions:

  • ICPI-AIE is a diverse neurological condition.
  • Neurologists will increasingly encounter ICPI-AIE.
  • Further research is needed on pathophysiology, epidemiology, and optimal treatment strategies.